Venous Stents Market
Report ID: SQMIG35A3037
Report ID: SQMIG35A3037
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35A3037 |
Region:
Global |
Published Date: June, 2025
Pages:
198
|Tables:
90
|Figures:
70
Global Venous Stents Market size was valued at USD 10.98 Billion in 2024 and is poised to grow from USD 11.6 Billion in 2025 to USD 17.93 Billion by 2033, growing at a CAGR of 5.6% during the forecast period (2026–2033).
The global venous stents market growth is being driven by a variety of factors, from increasing venous disease incidence to growing aging populations. As more patients seek effective treatment of diseases such as chronic venous insufficiency and deep vein thrombosis, demand for stenting solutions grows. Technological progress in stent technology through design and material is enabling better clinical outcomes, driving further market growth.
In addition, increasing patient and healthcare provider awareness of venous diseases is propelling the overall expansion of the global venous stents sector.
What Impact Does AI Have on Minimizing Risks in Venous Stent Treatments?
Through enhanced diagnosis, treatment planning, and stent design, artificial intelligence is increasingly revolutionizing the global venous stent industry. Through AI-based imaging technology, precise venous stent implantation is achieved, allowing physicians to analyze diagnostic images such as CT scans and ultrasounds more extensively. Through patient data analysis and stent recommendation, AI facilitates personalized treatment regimens. AI also enhances material design and stent design to enhance clinical outcomes.
Market snapshot - 2026-2033
Global Market Size
USD 10.4 billion
Largest Segment
Metallic
Fastest Growth
Biodegradable
Growth Rate
5.6% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Venous Stents Market is segmented by Technology, Product, Mode Of Delivery, Material, Stent Design, Placement of Stent, Indication, End-user and region. Based on Technology, the market is segmented into Drug-Eluting Stents, Bare Metal Stents, Covered Stents and Bioabsorbable Stents. Based on Product, the market is segmented into Coronary Stents, Peripheral Stents and Evar Stent Grafts. Based on Mode Of Delivery, the market is segmented into Balloon-Expandable Stents and Self-Expanding Stents. Based on Material, the market is segmented into Metallic Materials and Polymeric Materials. Based on Stent Design, the market is segmented into Braided, Laser-cut, Open-cell and Closed-cell. Based on Placement of Stent, the market is segmented into Lower Limbs, Thorax, Abdomen and Upper Limbs. Based on Indication, the market is segmented into Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Nutcracker Syndrome, Hemodialysis / Arteriovenous Fistulae and Others. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per the 2024 global venous stents market analysis, since self-expandable stents are automatically open upon deployment, they are the market leader and can be applied to patients suffering from complex coronary conditions. Self-expandable stents are used extensively due to their enhanced flexibility and lower restenosis rates. As per the latest data, self-expandable stents possess a commanding market share of more than 60%, fueled by the increase in cardiovascular diseases and advancements in stent design technology, especially during 2024–2025.
The balloon-expandable category is anticipated to have the highest venous stents market share due to their application in larger arteries and the increasing demand for less invasive procedures. Balloon-expandable stents are likely to witness greater market growth due to the increasing emphasis placed on making the stents more flexible and durable. Through the year 2025, balloon-expandable stents are projected to grow at a 5–8% annual rate.
Based on the 2024 global venous stents market forecast, given their strength, longevity, and biocompatibility, metallic stents are still the most sought material in the industry, especially when it comes to coronary artery treatments. There are several materials that provide long-term performance such as titanium, cobalt-chromium, and stainless steel and are used for metallic stents. Since they keep up with increasing demand for lasting and effective options for the cure of vascular illness, especially considering the breakthrough made in 2024, more than 70% of the market is held by them.
As advances in biodegradable material and design diminish the risk of long-term issues, biodegradable stents will be poised to experience significant growth. Biodegradable stents are increasingly being used, particularly in Europe, as concerns regarding environmental sustainability and patient concerns regarding implant lifespan increase. Through 2025, biodegradable stents will grow at a rate of 10–12% per annum.
To get detailed segments analysis, Request a Free Sample Report
As per the 2024 venous stents market regional forecast, the market is led by North America due to its sophisticated health care system and increasing prevalence of chronic venous diseases. There was a drastic rise in endovascular procedures across the region in 2024, with a high occurrence in the United States alone where more than 250,000 cases of deep vein thrombosis were identified. Hospitals are being compelled to install stERA technology at a quicker pace owing to the increasing population of old patients and insurance for minimally invasive procedures.
The U.S. venous stents market is thriving due to the enormous amount of clinical research and FDA-sanctioned technology. A novel self-expanding venous stent for iliofemoral blockages was approved by the FDA in 2024. With the backing of a patient base that's increasingly aware and demanding quicker recovery options, industry heavy hitters such as Cook Medical and Boston Scientific continue to innovate.
The Canadian venous stents market is slowly expanding because of increased investment in vascular medicine and interventional radiology. Access was expanded in 2025 when some provincial health systems started to reimburse treatment for chronic venous obstruction. Canadian hospitals are increasingly collaborating with U.S. providers for new-generation stent technology.
Europe has a great market share of venous stent because of the great number of procedures that occur in nations such as Germany and the UK. The region is favored with regulated medical procedures and strict regulation that stimulates innovation. Stents in hospitals have grown due to the European Society for Vascular Surgery's 2024 guidelines, which put an emphasis on early intervention of venous disease.
National Health Service (NHS) programs for promoting less invasive vascular interventions are leading the UK venous stents market. Venous interventions grew by 15% in 2024 from the previous year, according to NHS England. Universities and hospitals are partnering in research and development for next-generation stents to minimize restenosis risks.
France keeps investing in the production of medical devices and vascular research. Over 10,000 venous stenting procedures were conducted by French vascular specialists in 2024, and academic centers embraced this treatment in large quantities. In conclusion to its economy based on innovation, France also organized MedTech conferences where companies launched bioresorbable venous stents.
Germany is a prime location for venous stent development and uptake due to its strong medical device sector and specialized hospitals. Artificial intelligence -based diagnostic imaging was utilized in German hospitals in 2025 to diagnose venous blockages and enhance stenting patient selection. Public-private partnerships are driving both export market R&D and local demand.
As a result of increased access to vascular care, increased venous disease awareness, and increasing healthcare expenditures, Asia-Pacific is experiencing the most rapid growth in the venous stents market. India and China are driving market growth through volume and affordability, with South Korea and Japan driving clinical innovation.
Among the key drivers of Japan's venous stents market growth is Japan's rapidly growing population of aging people. In 2024, more than 29% of the population was 65 years or older, necessitating less invasive procedures. Medical universities in Japan are creating next-generation stents with anti-thrombogenic coatings to minimize complications in older patients.
The South Korean venous stents market is growing rapidly due to both a successful commercial hospital industry and government-funded innovation initiatives. Venous stenting procedures grew by 22% each year in 2025, as reported by Seoul National University Hospital. Korean companies are also penetrating the export market with compact, affordable venous stent solutions.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Incidence of Venous Chronic Disease
Advancements in Stent Design Technology
Costly Stent Procedures
Stringent Regulatory Requirements
Request Free Customization of this report to help us to meet your business objectives.
The global venous stents market is dominated by stiff competition among major players to establish market shares. Most often, competitive strategies such as product introductions, collaborations, acquisitions, and mergers are adopted. Stryker, for example, in January 2025 revealed that it will be acquiring Inari Medical for USD 4.9 billion to broaden its venous thromboembolism therapy portfolio. It demonstrates the competitiveness of the market coupled with the focus on growth and innovation.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, owing to technological developments in stents and the increased incidence of chronic venous diseases, the global venous stents market outlook is expected to change. While there are still barriers such as cost of treatment and legal issues, there is great potential in the increasing use of minimally invasive procedures and new market expansion. The market is marked by dynamic competition, with large companies aggressively pursuing strategic efforts to consolidate their market positions. Demand for successful venous stenting devices will continue to grow as patient education and healthcare systems evolve, driving innovation and business growth in the future years.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 10.98 Billion |
| Market size value in 2033 | USD 17.93 Billion |
| Growth Rate | 5.6% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Venous Stents Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Venous Stents Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Venous Stents Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Venous Stents Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
